OpenAlex 1.141 eser 11 yazar konusu
Çalışmalar
1.141 eser
-
Use of Short Peripheral Intravenous Catheters: Characteristics, Management, and Outcomes Worldwide 2018YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %1 OpenAlex 99.9%
BACKGROUND: Peripheral intravenous catheter (PIVC) use in health care is common worldwide. Failure of PIVCs is also common, resulting in premature removal and replacement. OBJECTIVE: To investigate the characteristics, management practices, and outcomes of PIVCs internationally. SETTING/PATIENTS: Cross-sectional study…
-
Use of Short Peripheral Intravenous Catheters: Characteristics, Management, and Outcomes Worldwide 2018YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %1 OpenAlex 99.9%
BACKGROUND: Peripheral intravenous catheter (PIVC) use in health care is common worldwide. Failure of PIVCs is also common, resulting in premature removal and replacement. OBJECTIVE: To investigate the characteristics, management practices, and outcomes of PIVCs internationally. SETTING/PATIENTS: Cross-sectional study…
-
Use of Short Peripheral Intravenous Catheters: Characteristics, Management, and Outcomes Worldwide 2018YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %1 OpenAlex 99.9%
BACKGROUND: Peripheral intravenous catheter (PIVC) use in health care is common worldwide. Failure of PIVCs is also common, resulting in premature removal and replacement. OBJECTIVE: To investigate the characteristics, management practices, and outcomes of PIVCs internationally. SETTING/PATIENTS: Cross-sectional study…
-
Use of Short Peripheral Intravenous Catheters: Characteristics, Management, and Outcomes Worldwide 2018YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %1 OpenAlex 99.9%
BACKGROUND: Peripheral intravenous catheter (PIVC) use in health care is common worldwide. Failure of PIVCs is also common, resulting in premature removal and replacement. OBJECTIVE: To investigate the characteristics, management practices, and outcomes of PIVCs internationally. SETTING/PATIENTS: Cross-sectional study…
-
YÖKSİS
SJR Q1
JCR Q1
OpenAlex üst %10
OpenAlex 96.1%
Özet henüz yok.
-
Phase I clinical trial of taxotere administered as either a 2-hour or 6-hour intravenous infusion. 1993OpenAlex üst %10 OpenAlex 97.7%
PURPOSE: To determine the potential efficacy and dose-limiting toxicity of taxotere, a hemisynthetic inhibitor of tubulin depolymerization. PATIENTS AND METHODS: Fifty-eight patients were administered taxotere in this phase I clinical trial as a 6-hour or a 2-hour infusion repeated every 21 days. Forty patients receiv…
-
YÖKSİS
SJR Q3
JCR Q3
OpenAlex 80.8%
BACKGROUND: To determine the incidence of early and late arrhythmogenic effects of doxorubicin-containing chemotherapy regimens. PATIENTS AND METHODS: A prospective study including 29 patients who were treated with doxorubicin-containing regimens. Cardiac evaluation was based on 24-hour electrocardiographic monitoriza…
-
OpenAlex 87.2%
BACKGROUND AND AIM: Androgenetic alopecia (AGA) is undoubtedly the most common form of hair loss in males. It is a condition which may cause cosmetic and psychosocial problems in androgen-dependent cases. In this open, randomized and comparative study we evaluated the efficacy of oral finasteride and 5% topical minoxi…
-
Design and evaluation of sustained-release and buccal adhesive propranolol hydrochloride tablets 1996OpenAlex üst %10 OpenAlex 95.2%
Özet henüz yok.
-
OpenAlex 81.8%
Doxorubicin is one of the most effective chemotherapeutic agents used in the treatment of malignancies. Cardiotoxicity is the most important dose-limiting toxicity of doxorubicin. Although cardiomyopathy is the most well known side effect of doxorubicin, it usually occurs many years after the treatment and relates to…
-
YÖKSİS
SJR Q1
JCR Q3
OpenAlex 81.8%
Doxorubicin is one of the most effective chemotherapeutic agents used in the treatment of malignancies. Cardiotoxicity is the most important dose-limiting toxicity of doxorubicin. Although cardiomyopathy is the most well known side effect of doxorubicin, it usually occurs many years after the treatment and relates to…
-
YÖKSİS
SJR Q2
JCR Q4
OpenAlex 67.9%
Özet henüz yok.
Akademisyenler
11 akademisyen
- SEVİNÇ KUTLUTÜRKAN 8 yazar konusu
- HANDAN BİLEN 6 yazar konusu
- HİKMETTİN DEMİR 5 yazar konusu
- BİLGE ÖZDEMİR 4 yazar konusu
- ŞEVKİ ÖZDEMİR 4 yazar konusu
- ELİF BİLSİN KOCAMAZ 3 yazar konusu
- NERİMAN YÜKSELTÜRK ŞİMŞEK 3 yazar konusu
- PELİN ERTOP DOĞAN 3 yazar konusu
- AYŞE ULU 2 yazar konusu
- NEVNİHAL AKBAYTÜRK 2 yazar konusu
- HATİCE FULYA YILMAZ 1 yazar konusu